Page last updated: 2024-12-07

o-methyltyrosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

o-Methyltyrosine, also known as 3-methoxytyrosine, is a synthetic analog of tyrosine. It acts as an inhibitor of tyrosine hydroxylase, the rate-limiting enzyme in the biosynthesis of catecholamines such as dopamine, norepinephrine, and epinephrine. o-Methyltyrosine has been studied for its potential therapeutic applications in various conditions, including hyperkinetic disorders like Parkinson's disease and Tourette's syndrome. Research has indicated that o-Methyltyrosine can effectively reduce the levels of dopamine in the brain, leading to a reduction in symptoms associated with these disorders. However, its use is limited due to potential side effects and the availability of alternative therapies. o-Methyltyrosine is typically synthesized through chemical reactions involving tyrosine and methanol.'

O-methyltyrosine: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

O-methyltyrosine : A tyrosine derivative that is tyrosine in which the hydroxy group at position 4 of the phenyl ring is substituted by a methoxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID97118
CHEBI ID192376
SCHEMBL ID158667
SCHEMBL ID12015202
MeSH IDM0042895

Synonyms (40)

Synonym
nsc30082
nsc-101132
nsc101132
3308-72-3
o-methyltyrosine
AKOS000179842
o-methyl-dl-tyrosine
CHEBI:192376
2-amino-3-(4-methoxyphenyl)propanoic acid
alpha-amino-4-methoxybenzenepropanoic acid
4-methoxyphenylalanine
2-azanyl-3-(4-methoxyphenyl)propanoic acid
A824771
nsc 101132
tyrosine, o-methyl-
7635-29-2
FT-0672301
FT-0618958
FT-0639582
4-methoxy-dl-phenylalanine
AB00243
AB02503
SCHEMBL158667
GEYBMYRBIABFTA-UHFFFAOYSA-N
AKOS016843211
SCHEMBL12015202
phenyltriethylammoniumchloride
mfcd00063071
h-4-methoxy-dl-phe-oh
h-dl-tyr(me)-oh
DTXSID80873658
SY044844
dl-4-methoxyphenylalanine
2-amino-3-(4-methoxyphenyl)propionic acid
S62T8L8FLU ,
FS-4576
unii-s62t8l8flu
CS-0373280
EN300-1723262
p-methoxy-dl-phenylalanine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
tyrosine derivativeAn amino acid derivative resulting from reaction of tyrosine at the amino group or the carboxy group, any substitution of phenyl hydrogens, or from the replacement of any hydrogen of tyrosine by a heteroatom. The definition normally excludes peptides containing tyrosine residues.
monomethoxybenzeneCompounds containing a benzene skeleton substituted with one methoxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's1 (6.25)18.2507
2000's10 (62.50)29.6817
2010's4 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.43 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.48 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]